Extended Data Fig. 9: Analysis of viral M1 antigen presentation of PROTAR vaccines. | Nature Microbiology

Extended Data Fig. 9: Analysis of viral M1 antigen presentation of PROTAR vaccines.

From: Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection

Extended Data Fig. 9

a, Viral M1 antigen presentation of PROTAR vaccines, IIV, CAIV, and WT virus. Raw264.7 cells were infected with indicated vaccines or viruses (MOI = 0.1) for 6 hours and detected for M1 antigen presentation on the surface of Raw264.7 cells by anti-M1 antibody (left) or an anti-M1 peptide (MGLIYNRM) antibody (right) using flow cytometry. Data are shown as means ± s.d.; n = 3 biological replicates; one-way ANOVA with Dunnett’s multiple comparisons test; black P values indicate the statistical comparison to WT group; orange P values indicate the statistical comparison to IIV group; blue P values indicate the statistical comparison to CAIV group; red P values indicate the statistical comparison to M1-PTD. b, Graphs showing the relevance between PTD-mediated antigen presentation and the levels of PROTAR vaccine-induced immune responses, including IgG antibody responses (top left), IgA antibody responses (top middle and right), T cellular responses against M1 antigen in lungs (bottom left), T cellular responses against NP antigen in lungs (bottom middle), and T cellular responses against NP in spleens (bottom right) (n = 5 mice per group). The same data for M1 antigen presentation are used in all the graphs.

Source data

Back to article page